| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.097 | 0.6 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |